AbbVie
ABBV
ABBV
1,761 hedge funds and large institutions have $80B invested in AbbVie in 2017 Q2 according to their latest regulatory filings, with 116 funds opening new positions, 657 increasing their positions, 728 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,761
Holders Change
+37
Holders Change %
+2.15%
% of All Funds
43.97%
Holding in Top 10
118
Holding in Top 10 Change
+35
Holding in Top 10 Change %
+42.17%
% of All Funds
2.95%
New
116
Increased
657
Reduced
728
Closed
61
Calls
$1.05B
Puts
$888M
Net Calls
+$162M
Net Calls Change
-$25.8M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$269M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$264M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$242M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$155M |
| 5 |
BlackRock
New York
|
+$135M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$230M |
| 2 |
State Street
Boston,
Massachusetts
|
-$114M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$86.4M |
| 4 |
Two Sigma Investments
New York
|
-$78.6M |
| 5 |
Bank of New York Mellon
New York
|
-$77.9M |
